- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Simvastatin gel may enhance osseointegration of Dental Implants, Study Finds
A groundbreaking study revealed that 1.2% simvastatin gel positively affects dental implant osseointegration. The results, published in The International Journal of Oral & Maxillofacial Implants, observed increased osteoblastic activity about four weeks after implant placement due to faster osseointegration at an early stage.
Dental implants are widely accepted treatment options for fully or partially edentulous patients. Implants undergo osseointegration, which integrates them with the natural bone. Osseointegration is essential for the success of the implants. Recent literature shows that simvastatin, a cholesterol-reducing drug, has been recently used to enhance osseointegration of dental implants. It is found to accelerate bone regeneration in bone defects. Hence, researchers used bone scintigraphy to estimate the effect of simvastatin gel in the osseointegration of dental implants.
A randomized controlled trial was carried out on about 20 participants with missing mandibular first molars and D2-type bone. The participants were assigned equally to two groups. Group A received 1.2% simvastatin, and Group B received placebo gels during implant placement. The participants were subjected to bone scintigraphy to determine the osteoblastic activity at baseline, 30 days, and 90 days after implant placement.
Findings:
- There was a significant increase in osteoblastic activity between baseline, day 30, and day 90 (P < .05) in group A.
- Group B showed a significant increase in osteoblastic activity only between baseline and day 30 and between baseline and day 90 (P < .05).
- No difference was observed between days 30 and 90 (P > .05), with a higher mean of 79.20% ± 18.255% on day 30.
- Groups A and B showed a significant difference in bivariate analysis performed at different periods on day 30.
Thus, the study concluded that 1.2% of simvastatin gel is efficient in osseointegration of implants. The researchers attributed this to enhanced osteoblastic activity, which hastened the osseointegration of implants.
Further reading: Maheshwaran KS, Banu R F, Kumar V A, Mohamed K. Comparative Evaluation of Simvastatin Gel in Enhancing Periimplant Osteoblastic Activity During the Osseointegration Phase Using Bone Scintigraphy: A Prospective Case-Control Double-Blinded Study. Int J Oral Maxillofac Implants. 2024;39(5):707-712. doi:10.11607/jomi.10741
BDS, MDS
Dr.Niharika Harsha B (BDS,MDS) completed her BDS from Govt Dental College, Hyderabad and MDS from Dr.NTR University of health sciences(Now Kaloji Rao University). She has 4 years of private dental practice and worked for 2 years as Consultant Oral Radiologist at a Dental Imaging Centre in Hyderabad. She worked as Research Assistant and scientific writer in the development of Oral Anti cancer screening device with her seniors. She has a deep intriguing wish in writing highly engaging, captivating and informative medical content for a wider audience. She can be contacted at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751